Literature DB >> 2274929

Recombinant human erythropoietin increases blood pressure, platelet aggregability and platelet free calcium mobilisation in uraemic children: a possible link?

C Van Geet1, R Van Damme-Lombaerts, M Vanrusselt, A de Mol, W Proesmans, J Vermylen.   

Abstract

Recombinant human erythropoietin was administered to 10 uraemic children on chronic haemodialysis, all of whom responded by correcting their haemoglobin. In addition, they showed an increase in blood pressure; platelet aggregations, subnormal before therapy, improved during treatment. The intracellular free calcium concentration in platelets after thrombin stimulation also increased significantly during erythropoietin administration. We hypothesize that the effect of erythropoietin on platelet aggregability and on blood pressure may be due to an increase in the intracellular free calcium mobilisation in platelets and possibly in smooth muscle cells respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2274929

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Low molecular weight heparin for anticoagulation during haemodialysis in children--a preliminary study.

Authors:  I Van Biljon; R Van Damme-Lombaerts; A Demol; C Van Geet; W Proesmans; J Arnout
Journal:  Eur J Pediatr       Date:  1996-01       Impact factor: 3.183

Review 2.  [Thrombocytopathy and blood complications in uremia].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2006-04       Impact factor: 1.704

Review 3.  Cardiovascular effects of erythropoietin an update.

Authors:  Anantha Vijay R Santhanam; Livius V d'Uscio; Zvonimir S Katusic
Journal:  Adv Pharmacol       Date:  2010

4.  An observational study to evaluate micronutrient status during enteral feeding.

Authors:  T E Johnson; S J Janes; A MacDonald; M Elia; I W Booth
Journal:  Arch Dis Child       Date:  2002-06       Impact factor: 3.791

5.  Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: results of a double-blind, placebo-controlled, randomized trial.

Authors:  Yi-Da Tang; Faisal Hasan; Frank J Giordano; Stephen Pfau; Henry M Rinder; Stuart D Katz
Journal:  Am Heart J       Date:  2009-12       Impact factor: 4.749

6.  Subcutaneous recombinant erythropoietin in preterminal renal insufficiency.

Authors:  C Van Geet; M Van Dyck; W Proesmans
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

7.  Hemoglobin target in chronic kidney disease: a pediatric perspective.

Authors:  Sai Ram Keithi-Reddy; Ajay K Singh
Journal:  Pediatr Nephrol       Date:  2008-07-05       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.